Wong Hing C, CEO of HCW Biologics Inc. ($HCWB), made three open market purchases of company shares over the past year, totaling about $2.5 million. His most recent buy occurred on May 16, 2025. These HCWB insider buys rank 270th among nearly 5,000 individuals in our database, above the average purchase of $1.5 million across 3 transactions. Wong Hing C reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | HCW Biologics Inc. | $HCWB | Wong Hing C | Chief Executive Officer | P | Common Stock | 8054 | $7.45 | 501,911.0000 | 44,934,120 | 1.63% | 0.02% |
| May 8, 2025 | HCW Biologics Inc. | $HCWB | Wong Hing C | Chief Executive Officer | P | Common Stock | 92500 | $26.00 | 493,857.0000 | 44,934,120 | 23.05% | 0.21% |
| May 7, 2025 | HCW Biologics Inc. | $HCWB | Wong Hing C | Chief Executive Officer | P | Common Stock Purchase Warrant | 46250 | $0.00 | 46,250.0000 | 44,934,120 | 9999.99% | 0.10% |
| Feb. 20, 2024 | HCW Biologics Inc. | $HCWB | Wong Hing C | Chief Executive Officer | A | Common Stock | 739288 | $1.40 | 16,054,156.0000 | 0 | 4.83% | 0.00% |